Babesia vaccines

Details for Australian Patent Application No. 2004260737 (hide)

Owner Intervet International B.V.

Inventors Gorenflot, Andre Francois; Cibrelus, Prisca Laetitia; Moubri, Karina; Depoix, Delphine; Carcy, Bernard Piere Dominique; Schetters, Theodorus Petrus Maria

Agent Spruson & Ferguson

Pub. Number AU-B-2004260737

PCT Pub. Number WO2005/012343

Priority 03077178.6 10.07.03 EP

Filing date 12 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 10 September 2009

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/018 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/44 (2006.01) Peptides having more than 20 amino acids

C07K 16/20 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2005/012343 Priority application(s): WO2005/012343

16 November 2006 Assignment before Grant

  Akzo Nobel N.V. The application has been assigned to Intervet International B.V.

10 September 2009 Application Accepted

  Published as AU-B-2004260737

14 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004260738-Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors

2004260735-Ink jet recording medium